Natural Killer (NK) Cell Therapeutics Market Report

Global and Region Natural Killer (NK) Cell Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：214
  • REPORT CODE：GMM1010119
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Natural Killer (NK) Cell Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Natural Killer (NK) Cell Therapeuticsmarket, defines the market attractiveness level of Natural Killer (NK) Cell Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Natural Killer (NK) Cell Therapeutics industry, describes the types of Natural Killer (NK) Cell Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Natural Killer (NK) Cell Therapeutics market and the development prospects and opportunities of Natural Killer (NK) Cell Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Natural Killer (NK) Cell Therapeutics market in Chapter 13.

    By Player:

    • Affimed NV (Netherlands)

    • Altor BioScience Corporation (USA)

    • Takeda Pharmaceutical (Japan)

    • Sorrento Therapeutics Inc (USA)

    • Innate Pharma SA (France)

    • Bristol-Myers Squibb (USA)

    • NantKwest Inc (USA)

    • NKT Therapeutics (USA)

    • Chipscreen Biosciences (China)

    By Type:

    • Mogamulizumab

    • Lorvotuzumab Mertansine

    • Others

    By End-User:

    • Cancer

    • Cardiovascular Diseases

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Natural Killer (NK) Cell Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Natural Killer (NK) Cell Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Natural Killer (NK) Cell Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Natural Killer (NK) Cell Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Natural Killer (NK) Cell Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)

    • 7.2 United States Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)

    • 7.3 Europe Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)

    • 7.4 China Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)

    • 7.5 Japan Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)

    • 7.6 India Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Natural Killer (NK) Cell Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Natural Killer (NK) Cell Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Natural Killer (NK) Cell Therapeutics Consumption Forecast (2022-2028)

    9 Global Natural Killer (NK) Cell Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Mogamulizumab Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lorvotuzumab Mertansine Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Natural Killer (NK) Cell Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Mogamulizumab Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Lorvotuzumab Mertansine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Natural Killer (NK) Cell Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Natural Killer (NK) Cell Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Natural Killer (NK) Cell Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Natural Killer (NK) Cell Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Natural Killer (NK) Cell Therapeutics Market Competitive Analysis

    • 14.1 Affimed NV (Netherlands)

      • 14.1.1 Affimed NV (Netherlands) Company Details

      • 14.1.2 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Product and Service

    • 14.2 Altor BioScience Corporation (USA)

      • 14.2.1 Altor BioScience Corporation (USA) Company Details

      • 14.2.2 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Product and Service

    • 14.3 Takeda Pharmaceutical (Japan)

      • 14.3.1 Takeda Pharmaceutical (Japan) Company Details

      • 14.3.2 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Product and Service

    • 14.4 Sorrento Therapeutics Inc (USA)

      • 14.4.1 Sorrento Therapeutics Inc (USA) Company Details

      • 14.4.2 Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Product and Service

    • 14.5 Innate Pharma SA (France)

      • 14.5.1 Innate Pharma SA (France) Company Details

      • 14.5.2 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Product and Service

    • 14.6 Bristol-Myers Squibb (USA)

      • 14.6.1 Bristol-Myers Squibb (USA) Company Details

      • 14.6.2 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Product and Service

    • 14.7 NantKwest Inc (USA)

      • 14.7.1 NantKwest Inc (USA) Company Details

      • 14.7.2 NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Product and Service

    • 14.8 NKT Therapeutics (USA)

      • 14.8.1 NKT Therapeutics (USA) Company Details

      • 14.8.2 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Product and Service

    • 14.9 Chipscreen Biosciences (China)

      • 14.9.1 Chipscreen Biosciences (China) Company Details

      • 14.9.2 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Natural Killer (NK) Cell Therapeutics

    • Figure Natural Killer (NK) Cell Therapeutics Picture

    • Table Global Natural Killer (NK) Cell Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Natural Killer (NK) Cell Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Natural Killer (NK) Cell Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Natural Killer (NK) Cell Therapeutics Consumption by Country (2017-2022)

    • Figure United States Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Natural Killer (NK) Cell Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Natural Killer (NK) Cell Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Natural Killer (NK) Cell Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mogamulizumab Consumption and Growth Rate (2017-2022)

    • Figure Global Lorvotuzumab Mertansine Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Mogamulizumab Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lorvotuzumab Mertansine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Natural Killer (NK) Cell Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Natural Killer (NK) Cell Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Affimed NV (Netherlands) (Foundation Year, Company Profile and etc.)

    • Table Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Product and Service

    • Table Altor BioScience Corporation (USA) (Foundation Year, Company Profile and etc.)

    • Table Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Product and Service

    • Table Takeda Pharmaceutical (Japan) (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Product and Service

    • Table Sorrento Therapeutics Inc (USA) (Foundation Year, Company Profile and etc.)

    • Table Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Product and Service

    • Table Innate Pharma SA (France) (Foundation Year, Company Profile and etc.)

    • Table Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Product and Service

    • Table Bristol-Myers Squibb (USA) (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Product and Service

    • Table NantKwest Inc (USA) (Foundation Year, Company Profile and etc.)

    • Table NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Product and Service

    • Table NKT Therapeutics (USA) (Foundation Year, Company Profile and etc.)

    • Table NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Product and Service

    • Table Chipscreen Biosciences (China) (Foundation Year, Company Profile and etc.)

    • Table Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US